RB Health
RB Health, a division of Reckitt Benckiser Group plc, is a leading player in the global health and hygiene industry, headquartered in the United States. Founded in 1823, the company has evolved significantly, focusing on consumer health products that enhance well-being. With a strong presence in North America, Europe, and Asia, RB Health is renowned for its innovative solutions in over-the-counter medications, personal care, and hygiene products. The company’s core offerings include well-known brands such as Nurofen, Strepsils, and Dettol, each distinguished by their commitment to quality and efficacy. RB Health has achieved notable market recognition, consistently ranking among the top health brands worldwide. With a focus on sustainability and consumer trust, RB Health continues to lead the way in health innovation, making a positive impact on global health standards.
DitchCarbon Score
How does RB Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RB Health's score of 30 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RB Health's reported carbon emissions
In 2022, RB Health reported total carbon emissions of approximately 140,620 kg CO2e, comprising Scope 1 emissions of about 5,150 kg CO2e, Scope 2 emissions of about 12,890 kg CO2e, and Scope 3 emissions of approximately 125,780 kg CO2e. The Scope 3 emissions included contributions from downstream transportation and distribution, employee commuting, and waste generated in operations. Historically, RB Health's emissions have varied significantly. For instance, in 2020, the company reported a substantial total of approximately 30,500,000 kg CO2e, with Scope 1 emissions at about 3,100,000 kg CO2e and Scope 2 emissions at approximately 2,600,000 kg CO2e. The majority of their emissions in 2020 were attributed to Scope 3, which accounted for about 30,500,000 kg CO2e. Despite the fluctuations in emissions, there are currently no specific reduction targets or initiatives disclosed by RB Health. The company has not committed to any science-based targets or climate pledges, indicating a potential area for future improvement in their sustainability strategy. Overall, RB Health's emissions data highlights the need for ongoing monitoring and potential action to enhance their climate commitments and reduce their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2012 | 2017 | 2018 | 2019 | 2020 | 2022 | |
|---|---|---|---|---|---|---|
| Scope 1 | 273,500,000 | 00,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000 |
| Scope 2 | 398,592,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 00,000 |
| Scope 3 | 1,882,000,000 | - | - | - | 00,000,000,000 | 000,000.00 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RB Health is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
